ARRS Opportunities and Obligations in Imaging Patients with Alzheimer’s Disease 2025

ARRS Opportunities and Obligations in Imaging Patients with Alzheimer’s Disease 2025

$45

Categories: - MUS, American Roentgen Ray Society (ARRS CME), Neurology, Psychiatry, Radiology, Uncategorized Tags: Alzheimer’s Dementia Imaging, Alzheimer’s Disease Amyloid PET, Alzheimer’s Disease DMT Imaging, Alzheimer’s Disease Imaging 2025, Alzheimer’s Disease Imaging Advanced Techniques, Alzheimer’s Disease Imaging Amyloid PET Reimbursement, Alzheimer’s disease imaging ARIA cases, Alzheimer’s Disease Imaging ARIA Surveillance, Alzheimer’s disease imaging ARRS 2025, Alzheimer’s Disease Imaging Benefits, Alzheimer’s Disease Imaging Best Practices, Alzheimer’s Disease Imaging Case Studies, Alzheimer’s Disease Imaging Challenges, Alzheimer’s Disease Imaging Clinical Implications, Alzheimer’s Disease Imaging CME, Alzheimer’s Disease Imaging Communication, Alzheimer’s disease imaging continuing education, Alzheimer’s Disease Imaging Course 2025, Alzheimer’s Disease Imaging Course ARRS, Alzheimer’s Disease Imaging Education, Alzheimer’s Disease Imaging Enterprise Workflow, Alzheimer’s disease imaging for clinicians, Alzheimer’s disease imaging for healthcare professionals, Alzheimer’s Disease Imaging for Medical Professionals, Alzheimer’s Disease Imaging for Neurologists, Alzheimer’s Disease Imaging for Radiologists, Alzheimer’s Disease Imaging Guidelines, Alzheimer’s disease imaging learning outcomes, Alzheimer’s disease imaging lectures, Alzheimer’s disease imaging modules, Alzheimer’s Disease Imaging Multidisciplinary, Alzheimer’s Disease Imaging Multidisciplinary Approach, Alzheimer’s disease imaging multimodal, Alzheimer’s disease imaging new therapies, Alzheimer’s Disease Imaging Online Course, Alzheimer’s Disease Imaging Opportunities, Alzheimer’s Disease Imaging Optimization, Alzheimer’s disease imaging patient management, Alzheimer’s Disease Imaging Patient Selection, Alzheimer’s disease imaging PET MRI, Alzheimer’s disease imaging professional development, Alzheimer’s disease imaging radiology perspective, Alzheimer’s disease imaging reimbursement, Alzheimer’s Disease Imaging Risks, Alzheimer’s disease imaging speakers, Alzheimer’s disease imaging surveillance, Alzheimer’s disease imaging team approach, Alzheimer’s Disease Imaging Training, Alzheimer’s disease imaging treatment surveillance, Alzheimer’s disease imaging updates 2025, Alzheimer’s Disease Imaging Workflow, Alzheimer’s disease imaging workflow optimization, Alzheimer’s Disease Molecular Imaging, Alzheimer’s Disease MRI, Alzheimer’s disease MRI protocols, Alzheimer’s Disease MRI Volume, Alzheimer’s Disease Radiology, Alzheimer’s Disease Radiology Course, Alzheimer’s Disease Treatment Surveillance Imaging, Amyloid PET Imaging, amyloid PET reimbursement, anti-amyloid therapies imaging, Anti-amyloid Therapy Imaging, ARIA Grading in Imaging, ARIA surveillance, ARRS Alzheimer’s course, ARRS Alzheimer’s Disease CME, ARRS Alzheimer’s Disease Course, ARRS Alzheimer’s Disease Education, ARRS Alzheimer’s Disease Imaging 2025, ARRS Alzheimer’s Disease Imaging Amyloid PET, ARRS Alzheimer’s Disease Imaging Course, ARRS Alzheimer’s Disease Imaging DMT, ARRS Alzheimer’s Disease Imaging Learning Outcomes, ARRS Alzheimer’s Disease Imaging Lectures, ARRS Alzheimer’s Disease Imaging Modules, ARRS Alzheimer’s Disease Imaging MRI, ARRS Alzheimer’s Disease Imaging Multimodal, ARRS Alzheimer’s Disease Imaging Obligations, ARRS Alzheimer’s Disease Imaging Opportunities, ARRS Alzheimer’s Disease Imaging Speakers, ARRS Alzheimer’s Disease Imaging Surveillance, ARRS Alzheimer’s Disease Imaging Workflow, ARRS Alzheimer’s Disease Online Course, ARRS Alzheimer’s Disease Training, ARRS dementia imaging, ARRS Dementia Imaging Course, ARRS imaging CME, ARRS imaging course 2025, ARRS Imaging Opportunities and Obligations, ARRS imaging training, ARRS online course Alzheimer’s, ARRS online education, ARRS radiology education, Dementia Imaging Pathway, Disease-Modifying Therapies Alzheimer’s, molecular imaging Alzheimer’s, MRI in Alzheimer’s disease, multidisciplinary dementia imaging, Multimodal Dementia Imaging, radiology Alzheimer’s disease Brand: CMEMEDCOM

Description

Date of Original Release: Aug 2025

Anti-amyloid targeting disease-modifying therapies for Alzheimer’s disease present an exciting opportunity to dramatically impact the lives of patients with Alzheimer’s dementia. The imaging impact is already formidable, with a significant rise in MRI volume. Amyloid PET volumes have also skyrocketed following a positive reimbursement decision for patient selection and treatment surveillance.

Learning Outcomes and Modules

After completing this course, the learner should be able to:

Identify the challenges and opportunities of AD in the era of DMT.
Discuss the benefits and risks of amyloid targeting therapies.
Discuss clinical implications of ARIA grading and multidisciplinary communication.
Recognize the role of molecular imaging in the dementia imaging pathway.

Speakers and Lectures

Multimodal Dementia Imaging with Emphasis on Alzheimer’s Disease and ARIA Cases—Suzie Bash
Enterprise Workflow Optimization for Alzheimer’s Screening and ARIA Surveillance—Lawrence Tanenbaum
Radiology Perspective: Multidisciplinary Approach to Challenging Cases—Tammie Benzinger

Video sample and details : https://arrs.org/ARRSLIVE/ARRSLIVE/Education/OnlineCourses/OC_CC25CA.aspx